Meridian Wealth Partners’s Wave Life Sciences WVE Stock Holding History

Meridian Wealth Partners’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-49	Closed	–	–	1290
2021 Q1	$0	Buy	+49	New	+$471	﹤0.01%	1476

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meridian Wealth Partners's WVE Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 49 shares.

Meridian Wealth Partners first reported a position in WVE in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

Meridian Wealth Partners reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 49 Wave Life Sciences shares in Q2 2021.
Meridian Wealth Partners first reported a position in Wave Life Sciences in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Wave Life Sciences position peaked at $0 in Q1 2021.
87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.